Daiwa Securities Group’s CorMedix CRMD Stock Holding History

Daiwa Securities Group’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$992K	Hold	126,400	–	–	﹤0.01%	827
2026 Q1	$255K	Buy	+126,400	New	+$934K	﹤0.01%	1006

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Daiwa Securities Group's CRMD Position: Q2 2026 in Review

Daiwa Securities Group held its CorMedix (CRMD) position steady in Q2 2026 at 126,400 shares worth $992K. The position accounts for ﹤0.01% of the portfolio, ranked #826.

Daiwa Securities Group first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Daiwa Securities Group held 126,400 shares of CorMedix worth $992K as of Q2 2026.
Daiwa Securities Group left its CorMedix share count unchanged in Q2 2026.
CorMedix made up ﹤0.01% of Daiwa Securities Group's portfolio in Q2 2026, its #826 holding.
Daiwa Securities Group first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Daiwa Securities Group's 13F filing for Q2 2026, filed 31 Jul 2026.